GSAC News Alert Gelstat Corp (GSAC) 0.0400 09/27/2014 22:33:
Post# of 273249
Posted On: 09/27/2014 11:33:39 PM
Gelstat Corp (GSAC) 0.0400 $GSAC
GelStat Corporation Reports Second Quarter Results and Provides Shareholder Update
Marketwire - Tue Aug 19, 6:03AM CDT
GelStat Corporation (PINKSHEETS: GSAC), a fully integrated consumer healthcare company engaged in the research, development, marketing and branding of innovative over-the-counter (OTC) consumer healthcare products addressing very large markets, reported results for the period ended June 30, 2014 and is updating shareholders on recent events.
GelStat Corporation Acquires Mastix Medica, LLC for Restricted Common Stock
Marketwire - Tue Jul 08, 6:55AM CDT
GelStat Corporation (PINKSHEETS: GSAC), a company engaged in the research, development, marketing, licensing and branding of innovative Over-the-Counter (OTC) consumer healthcare products, is pleased to announce it has closed the acquisition of Mastix Medica, LLC on July 7, 2014. GelStat acquired 100% of the membership equity in Mastix Medica, LLC in exchange for 27,500,000 restricted shares in GelStat's common stock. In conjunction with the closing of this acquisition, GelStat launches a new corporate website which can be viewed at www.Gelstat.com
GelStat Signs Distribution Agreement With Windmill Health Products for the Distribution of "Chews 2 Lose" Appetite Suppressant Gum
Marketwire - Tue Jun 24, 6:05AM CDT
GelStat Corporation (PINKSHEETS: GSAC), a company engaged in the research, development, marketing and branding of innovative dietary supplements and Over-the-Counter (OTC) consumer healthcare products, is pleased to announce today that it has launched its new weight loss diet aide "Chews 2 Lose Appetite Suppressant Gum" and has signed a distribution agreement with Windmill Health Products. Windmill serves over 3,500 independent pharmacies and is initially placing "Chews 2 Lose Appetite Suppressant Gum" in 300 of these pharmacies.
Roger Cady, M.D. Joins GelStat Corporation as Chief Medical Advisor
Marketwire - Tue Apr 01, 6:03AM CDT
GelStat Corporation (PINKSHEETS: GSAC), a company engaged in the research, development, marketing and branding of innovative Over-the-Counter (OTC) consumer healthcare products, is pleased to announce today that Roger Cady, M.D. has agreed to become the GelStat's Chief Medical Advisor and to assist the Company with developing several of its new migraine products.
Commercial Construction in Romania to 2017: Market Forecast Report
M2 - Tue Feb 04, 3:45AM CST
Research and Markets (http://www.researchandmarkets.com/research/r925ks/commercial) has announced the addition of the "Commercial Construction in Romania to 2017: Market Forecast" report to their offering. 'Commercial Construction in Romania to 2017: Market Forecast' contains detailed historic and forecast market value data for the commercial construction industry, including a breakdown of the data by construction activity (new construction, repair and maintenance, refurbishment and demolition). The databook provides historical and forecast valuations of the industry using the construction output and value-add methods. This report is the result of extensive market research covering the commercial construction industry in Romania. It contains detailed historic and forecast market value data for the commercial construction industry, including a breakdown of the data by construction activity (new construction, repair and maintenance, refurbishment and demolition). 'Commercial Construction in Romania to 2017: Market Forecast' provides a top-level overview and detailed insight into the operating environment of the commercial construction industry in Romania. It is an essential tool for companies active across the Romanian construction value chain and for new players considering to enter the market. Scope - Overview of the commercial construction industry in Romania. - Historic and forecast market value for the commercial construction industry by construction output and value-add methods for the period 2008 through to 2017. - Historic and forecast market value by construction activity (new construction, repair and maintenance, refurbishment and demolition) across the commercial construction industry for the period 2008 through to 2017. Key Topics Covered: Introduction Commercial Construction: Industry Analysis Commercial Construction: Activity Breakdown Leisure & Hospitality Buildings: Category Analysis Office Buildings: Category Analysis Outdoor Leisure Facilities: Category Analysis Retail Buildings: Category Analysis Other Commercial Construction: Category Analysis Appendix List of Tables List of Figures For more information visit http://www.researchandmarkets.com/research/r925ks/commercial About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
GelStat Corporation Received Initial Purchase Order From Windmill Health Products
Marketwire - Mon Jan 27, 6:05AM CST
GelStat Corporation (PINKSHEETS: GSAC), a company engaged in the research, development, marketing and branding of innovative Over-the-Counter (OTC) consumer healthcare products, is pleased to announce today that it has received the initial purchase order from Windmill Health Products. Windmill serves over 3,000 independent pharmacies and is initially placing Gelstat Migraine in 200 independent pharmacies throughout the northeast.
GelStat Corporation Executes Letter of Intent to Acquire a Deep Product Pipeline and Appoint Highly Accomplished Marketing Executive to Lead Company
Marketwire - Mon Jun 10, 6:10AM CDT
GelStat Corporation (PINKSHEETS: GSAC), a consumer healthcare company primarily focused on the development and marketing of over-the-counter (OTC) products, is pleased to announce that it has executed a Letter of Intent (LOI) to acquire the rights to multiple products presently under the control of Larry Gershman. The transaction is subject to the completion of standard due diligence and closing conditions. The transaction is expected to close within 45 days.
GelStat Corporation Reports Second Quarter Results and Provides Shareholder Update
Marketwire - Tue Aug 19, 6:03AM CDT
GelStat Corporation (PINKSHEETS: GSAC), a fully integrated consumer healthcare company engaged in the research, development, marketing and branding of innovative over-the-counter (OTC) consumer healthcare products addressing very large markets, reported results for the period ended June 30, 2014 and is updating shareholders on recent events.
GelStat Corporation Acquires Mastix Medica, LLC for Restricted Common Stock
Marketwire - Tue Jul 08, 6:55AM CDT
GelStat Corporation (PINKSHEETS: GSAC), a company engaged in the research, development, marketing, licensing and branding of innovative Over-the-Counter (OTC) consumer healthcare products, is pleased to announce it has closed the acquisition of Mastix Medica, LLC on July 7, 2014. GelStat acquired 100% of the membership equity in Mastix Medica, LLC in exchange for 27,500,000 restricted shares in GelStat's common stock. In conjunction with the closing of this acquisition, GelStat launches a new corporate website which can be viewed at www.Gelstat.com
GelStat Signs Distribution Agreement With Windmill Health Products for the Distribution of "Chews 2 Lose" Appetite Suppressant Gum
Marketwire - Tue Jun 24, 6:05AM CDT
GelStat Corporation (PINKSHEETS: GSAC), a company engaged in the research, development, marketing and branding of innovative dietary supplements and Over-the-Counter (OTC) consumer healthcare products, is pleased to announce today that it has launched its new weight loss diet aide "Chews 2 Lose Appetite Suppressant Gum" and has signed a distribution agreement with Windmill Health Products. Windmill serves over 3,500 independent pharmacies and is initially placing "Chews 2 Lose Appetite Suppressant Gum" in 300 of these pharmacies.
Roger Cady, M.D. Joins GelStat Corporation as Chief Medical Advisor
Marketwire - Tue Apr 01, 6:03AM CDT
GelStat Corporation (PINKSHEETS: GSAC), a company engaged in the research, development, marketing and branding of innovative Over-the-Counter (OTC) consumer healthcare products, is pleased to announce today that Roger Cady, M.D. has agreed to become the GelStat's Chief Medical Advisor and to assist the Company with developing several of its new migraine products.
Commercial Construction in Romania to 2017: Market Forecast Report
M2 - Tue Feb 04, 3:45AM CST
Research and Markets (http://www.researchandmarkets.com/research/r925ks/commercial) has announced the addition of the "Commercial Construction in Romania to 2017: Market Forecast" report to their offering. 'Commercial Construction in Romania to 2017: Market Forecast' contains detailed historic and forecast market value data for the commercial construction industry, including a breakdown of the data by construction activity (new construction, repair and maintenance, refurbishment and demolition). The databook provides historical and forecast valuations of the industry using the construction output and value-add methods. This report is the result of extensive market research covering the commercial construction industry in Romania. It contains detailed historic and forecast market value data for the commercial construction industry, including a breakdown of the data by construction activity (new construction, repair and maintenance, refurbishment and demolition). 'Commercial Construction in Romania to 2017: Market Forecast' provides a top-level overview and detailed insight into the operating environment of the commercial construction industry in Romania. It is an essential tool for companies active across the Romanian construction value chain and for new players considering to enter the market. Scope - Overview of the commercial construction industry in Romania. - Historic and forecast market value for the commercial construction industry by construction output and value-add methods for the period 2008 through to 2017. - Historic and forecast market value by construction activity (new construction, repair and maintenance, refurbishment and demolition) across the commercial construction industry for the period 2008 through to 2017. Key Topics Covered: Introduction Commercial Construction: Industry Analysis Commercial Construction: Activity Breakdown Leisure & Hospitality Buildings: Category Analysis Office Buildings: Category Analysis Outdoor Leisure Facilities: Category Analysis Retail Buildings: Category Analysis Other Commercial Construction: Category Analysis Appendix List of Tables List of Figures For more information visit http://www.researchandmarkets.com/research/r925ks/commercial About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
GelStat Corporation Received Initial Purchase Order From Windmill Health Products
Marketwire - Mon Jan 27, 6:05AM CST
GelStat Corporation (PINKSHEETS: GSAC), a company engaged in the research, development, marketing and branding of innovative Over-the-Counter (OTC) consumer healthcare products, is pleased to announce today that it has received the initial purchase order from Windmill Health Products. Windmill serves over 3,000 independent pharmacies and is initially placing Gelstat Migraine in 200 independent pharmacies throughout the northeast.
GelStat Corporation Executes Letter of Intent to Acquire a Deep Product Pipeline and Appoint Highly Accomplished Marketing Executive to Lead Company
Marketwire - Mon Jun 10, 6:10AM CDT
GelStat Corporation (PINKSHEETS: GSAC), a consumer healthcare company primarily focused on the development and marketing of over-the-counter (OTC) products, is pleased to announce that it has executed a Letter of Intent (LOI) to acquire the rights to multiple products presently under the control of Larry Gershman. The transaction is subject to the completion of standard due diligence and closing conditions. The transaction is expected to close within 45 days.
(0)
(0)Scroll down for more posts ▼